FindTrial
Sign In

Association of contrast dosage and slow-flow or no-reflow phenomenon after percutaneous transluminal coronary angioplasty and stent for patients with non-ST-segment elevation acute coronary syndrome-a case control study

Association of contrast dosage and slow-flow or no-reflow phenomenon after percutaneous transluminal coronary angioplasty and stent for patients with non-ST-segment elevation acute coronary syndrome-a case control study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RRC-17012095
Enrollment
Unknown
Registered
2017-07-23
Start date
2017-08-01
Completion date
Unknown
Last updated
2017-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-ST-segment elevation acute coronary syndrome

Interventions

case group:none
control group:none

Sponsors

The Eighth Hospital of Qingdao
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients with the diagnosis of non-ST segment elevation acute coronary syndrome receiving percutaneous coronary intervention after being hospitalized.

Exclusion criteria

Exclusion criteria: 1. Patients with coronary artery stent stenosis receiving percutaneous transluminal coronary angioplasty and stent; 2. Patients with bridge blood vessel receiving percutaneous transluminal coronary angioplasty and stent; 3. Patients receiving coronary rotablation.

Design outcomes

Primary

MeasureTime frame
contrast dosage;TIMI grade of coronary blood flow;—

Countries

China

Contacts

Public ContactSihua Ding

The Eighth Hospital of Qingdao

dsh1226@163.com+86 13964830753

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026